170 related articles for article (PubMed ID: 31472989)
1. Synthesis, toxicity and antitumor activity of cobalt carbonyl complexes targeting hepatocellular carcinoma.
Li J; Zhang J; Zhang Q; Wang Y; Bai Z; Zhao Q; He D; Wang Z; Zhang J; Chen Y
Bioorg Med Chem; 2019 Oct; 27(20):115071. PubMed ID: 31472989
[TBL] [Abstract][Full Text] [Related]
2. Induction of Apoptosis by Nano-Synthesized Complexes of H2L and its Cu(II) Complex in Human Hepatocellular Carcinoma Cells.
Diab T; Mohamed TM; Hamed A; Gaber M
Anticancer Agents Med Chem; 2021; 21(9):1151-1159. PubMed ID: 32013853
[TBL] [Abstract][Full Text] [Related]
3. Toxicity, bio-distribution and metabolism of CO-releasing molecules based on cobalt.
Gong Y; Zhang T; Li M; Xi N; Zheng Y; Zhao Q; Chen Y; Liu B
Free Radic Biol Med; 2016 Aug; 97():362-374. PubMed ID: 27375229
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, toxicities and bio-activities of manganese complexes with CO and H
Bai Z; Zhang J; Zhang Q; Zhang T; Li J; Zhao Q; Wang Z; He D; Cheng J; Zhang J; Liu B
Eur J Med Chem; 2018 Nov; 159():339-356. PubMed ID: 30308409
[TBL] [Abstract][Full Text] [Related]
5. Antitumor effects of ginsenoside Rg3 on human hepatocellular carcinoma cells.
Zhang C; Liu L; Yu Y; Chen B; Tang C; Li X
Mol Med Rep; 2012 May; 5(5):1295-8. PubMed ID: 22366885
[TBL] [Abstract][Full Text] [Related]
6. Syntheses and anti-cancer activity of CO-releasing molecules with targeting galactose receptors.
Li J; Zhang J; Zhang Q; Bai Z; Zhao Q; He D; Wang Z; Chen Y; Liu B
Org Biomol Chem; 2018 Nov; 16(43):8115-8129. PubMed ID: 30334056
[TBL] [Abstract][Full Text] [Related]
7. Anti-Cancer Effects of Citalopram on Hepatocellular Carcinoma Cells Occur via Cytochrome C Release and the Activation of NF-kB.
Ahmadian E; Eftekhari A; Babaei H; Nayebi AM; Eghbal MA
Anticancer Agents Med Chem; 2017 Nov; 17(11):1570-1577. PubMed ID: 28356024
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and biochemical studies of novel organic selenides with increased selectivity for hepatocellular carcinoma and breast adenocarcinoma.
Shaaban S; Ashmawy AM; Negm A; Wessjohann LA
Eur J Med Chem; 2019 Oct; 179():515-526. PubMed ID: 31276896
[TBL] [Abstract][Full Text] [Related]
9. Design, synthesis and biological evaluation of novel 1,3,4-trisubstituted pyrazole derivatives as potential chemotherapeutic agents for hepatocellular carcinoma.
Harras MF; Sabour R
Bioorg Chem; 2018 Aug; 78():149-157. PubMed ID: 29567429
[TBL] [Abstract][Full Text] [Related]
10. The antiproliferative effect of spectinabilins from Streptomyces spectabilis on hepatocellular carcinoma cells in vitro and in vivo.
Gao X; Yao H; Mu Y; Guan P; Li G; Lin B; Jiang Y; Han L; Huang X; Jiang C
Bioorg Chem; 2019 Dec; 93():103311. PubMed ID: 31586709
[TBL] [Abstract][Full Text] [Related]
11. Apoptotic effect of chromanone derivative, hyrtiosone A from marine demosponge Hyrtios erectus in hepatocellular carcinoma HepG2 cells.
Chakraborty K; Francis P
Bioorg Chem; 2021 Sep; 114():105119. PubMed ID: 34252861
[TBL] [Abstract][Full Text] [Related]
12. Discovery of penipanoid C-inspired 2-(3,4,5-trimethoxybenzoyl)quinazolin-4(3H)-one derivatives as potential anticancer agents by inhibiting cell proliferation and inducing apoptosis in hepatocellular carcinoma cells.
Wang CJ; Guo X; Zhai RQ; Sun C; Xiao G; Chen J; Wei MY; Shao CL; Gu Y
Eur J Med Chem; 2021 Nov; 224():113671. PubMed ID: 34237623
[TBL] [Abstract][Full Text] [Related]
13. Antitumor properties of certain spirooxindoles towards hepatocellular carcinoma endowed with antioxidant activity.
Al-Rashood ST; Hamed AR; Hassan GS; Alkahtani HM; Almehizia AA; Alharbi A; Al-Sanea MM; Eldehna WM
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):831-839. PubMed ID: 32208781
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis, molecular modelling, and biological evaluation of novel substituted pyrimidine derivatives as potential anticancer agents for hepatocellular carcinoma.
Ahmed NM; Youns M; Soltan MK; Said AM
J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1110-1120. PubMed ID: 31117890
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of Polo-Like Kinase 1 by BI2536 Reverses the Multidrug Resistance of Human Hepatoma Cells In Vitro and In Vivo.
Li HY; Luo F; Li XY; Fu XF; He JF; Tian YZ; Zhu JJ; Chu XY; Zhao HL
Anticancer Agents Med Chem; 2019; 19(6):740-749. PubMed ID: 30836927
[TBL] [Abstract][Full Text] [Related]
16. New manganese(II), iron(II), cobalt(II), nickel(II) and copper(II) saccharinate complexes of 2,6-bis(2-benzimidazolyl)pyridine as potential anticancer agents.
Icsel C; Yilmaz VT; Aydinlik Ş; Aygun M
Eur J Med Chem; 2020 Sep; 202():112535. PubMed ID: 32653697
[TBL] [Abstract][Full Text] [Related]
17. Involvement of the prostaglandin E receptor EP2 in paeoniflorin-induced human hepatoma cell apoptosis.
Hu S; Sun W; Wei W; Wang D; Jin J; Wu J; Chen J; Wu H; Wang Q
Anticancer Drugs; 2013 Feb; 24(2):140-9. PubMed ID: 23069790
[TBL] [Abstract][Full Text] [Related]
18. Co-SLD suppressed the growth of oral squamous cell carcinoma via disrupting mitochondrial function.
Li S; Li G; Zhang T; Li J; Zhao Q; Zhang B; Wang R; Zhou R; Si J; Gan L; Liu Y; Zhang H; Liu B
Artif Cells Nanomed Biotechnol; 2019 Dec; 47(1):1746-1757. PubMed ID: 31062618
[TBL] [Abstract][Full Text] [Related]
19. Trifluoromethyl-substituted 3,5-bis(arylidene)-4-piperidones as potential anti-hepatoma and anti-inflammation agents by inhibiting NF-кB activation.
Cong W; Sun Y; Sun YF; Yan WB; Zhang YL; Gao ZF; Wang CH; Hou GG; Zhang JJ
J Enzyme Inhib Med Chem; 2021 Dec; 36(1):1622-1631. PubMed ID: 34284695
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and Anticancer Activity of Benzimidazole/Benzoxazole Substituted Triazolotriazines in Hepatocellular Carcinoma.
Dadashpour S; Küçükkılınç TT; Ercan A; Hosseinimehr SJ; Naderi N; Irannejad H
Anticancer Agents Med Chem; 2019; 19(17):2120-2129. PubMed ID: 31393257
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
